We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Gastric Stimulation Device Helps Battle Obesity

By HospiMedica International staff writers
Posted on 17 Jan 2011
An implantable stimulation system that tracks food consumption events and physical activity offers an alternative to gastric surgery for the treatment of obesity.

The abiliti system detects when a person eats or drinks via implanted sensors, and sends in return low-level electrical impulses to the stomach, customized to the needs of each individual patient. More...
This stimulation is intended to help the person feel sated before the stomach is actually full, causing them to eat less. The system also automatically records when a patient eats, drinks, and exercises; using a simple wireless connection, the patients and physicians can then view consumption and exercise data, helping them understand patient behavior and develop effective strategies for weight loss.

As the anatomy of the stomach is not changed, the abiliti system shows virtually none of the nausea and other side effects seen with gastric bypass surgery and gastric banding. Patients are not restricted in the types of food that they consume, and are encouraged to adopt a healthy diet and exercise program. The system also connects patients to a valuable social support network, support which research has demonstrated increases the effectiveness of weight loss programs. The abiliti system is a product of IntraPace (Mountain View, CA, USA), and has received the European Community (CE) Marking of approval.

"The incidence of obesity among the world's population continues to grow each year, creating a huge demand for effective solutions. The abiliti system provides a patient-friendly solution that we believe many people considering weight loss surgery will find attractive,” said Chuck Brynelsen, president and CEO of IntraPace.

"While gastric banding, sleeve gastrectomy, and gastric bypass are very effective treatments for obesity, they alter the digestive tract and are often associated with significant side effects. These side effects make many potential patients reluctant to choose these procedures,” said Professor Thomas Horbach, MD, chief of surgery at Stadtkrankenhaus Schwabach (Germany). "Patients receiving the abiliti system achieved substantial weight loss with almost none of the side effects seen with other bariatric interventions. This therapy addresses the biggest limitation of the established bariatric procedures.”

Related Links:
IntraPace
Stadtkrankenhaus Schwabach



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Syringes
Prefilled Saline Flush Syringes
Open Stapler
PROXIMATE Linear Cutter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.